Neoadjuvant Anlotinib and Epirubicin for T4 Sinonasal Adenoid Cystic Carcinoma
Clinical trial NCT07616141 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07616141
- Sponsor
- Eye & ENT Hospital of Fudan University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-01
- Primary completion
- 2028-06-01
- Enrollment
- 76
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.